GlaxoSmithKline Pharmaceuticals has reported results for fourth quarter and year ended December 31, 2012.
The company has reported 15.61% fall in its net profit at Rs 116.88 crore for the quarter as compared to Rs 138.51 crore for the same quarter in the previous year. Total income of the company has decreased by 2.74% at Rs 685.04 crore for quarter under review as compared to Rs 704.34 crore for the quarter ended December 31, 2012.
For the year ended December 31, 2013, the company has posted a fall of 13.05% in its net profit at Rs 501.88 crore as compared to Rs 577.26 crore for the same period in the previous year. Total income of the company has decreased by 2.71% at Rs 2747.12 crore for year under review as compared to Rs 2823.78 crore for the period ended December 31, 2012.
For the year ended December 31, 2013, on consolidated basis, the company has posted a fall of 14.27% in its net profit at Rs 481.67 crore as compared to Rs 561.88 crore for the same period in the previous year. Total income from operation has decreased by 3.01% at Rs 2739.64 crore for year under review as compared to Rs 2824.85 crore for the period ended December 31, 2012.
